Impact of Intranasal Administration of Fresh Breast Milk in Very Low Birth Weight Infants With Germinal Matrix-Intraventricular Hemorrhage
Authors:
- Gulay Sonmez DemirGDGulay Sonmez Demir
- Ozmert Ozdemir Sr.OSOzmert Ozdemir Sr.
Open Access
- 11 March 2025
- journal article
- Published by Springer Nature in Cureus
- Vol. 17 (3) , e80416
Abstract
There are no specific treatment modalities that prevent the progression of germinal matrix and intraventricular hemorrhage (GM-IVH) once it occurs. Breast milk is rich in mesenchymal stem cells, extracellular vesicles, and neurotrophins, all of which have been shown to have therapeutic effects. Intranasal drug administration has been demonstrated to be a reliable method for delivering various therapeutic agents directly to the brain via the olfactory nerve pathway. In this study, we aimed to evaluate the neuroprotective role of intranasal breast milk in very low birth weight (VLBW) infants with GM-IVH by assessing ventricular dilation and GM-IVH size on ultrasound, as well as neurodevelopmental outcomes using the Bayley-III scale. This study included 22 VLBW infants diagnosed with GM-IVH in the first postnatal week. A total of 11 infants received intranasal breast milk (inFBM) for at least 28 days or until discharge, while 11 infants in the control group received standard treatment. Patients were clinically monitored via cranial transfontanelle ultrasonography. A total of 14 patients from both groups were evaluated using the Bayley-III Infant Developmental Screening Scale. The incidence of posthemorrhagic ventricular dilation (PHVD) was significantly lower in the study group than in the control group (p = 0.010). In addition, the incidence of grade regression in the transfontanelle ultrasonography findings at discharge was significantly greater in the study group than in the control group (p = 0.008). Moreover, the incidence of retinopathy of prematurity was lower in the study group than in the control group. Compared with non-administration, the intranasal administration of fresh breast milk to VLBW premature infants with GM-IVH results in regression of GM-IVH and significantly reduces progression to posthemorrhagic ventricular dilation. It may also reduce the incidence of retinopathy of prematurity.Keywords
This publication has 30 references indexed in Scilit:
- Intranasal Delivery of Mesenchymal Stem Cells-Derived Extracellular Vesicles for the Treatment of Neurological DiseasesStem Cells, 2021
- Mesenchymal stem cell therapy for intractable neonatal disordersPediatrics & Neonatology, 2021
- Human Breast Milk-Derived Extracellular Vesicles in the Protection Against Experimental Necrotizing EnterocolitisJournal of Pediatric Surgery, 2020
- Intraventricular hemorrhage and posthemorrhagic hydrocephalus in preterm infants: diagnosis, classification, and treatment optionsChild's Nervous System, 2019
- Intranasal breast milk for premature infants with severe intraventricular hemorrhage—an observationEuropean Journal of Pediatrics, 2018
- Mesenchymal stem cells: immune evasive, not immune privilegedNature Biotechnology, 2014
- Intranasal epidermal growth factor treatment rescues neonatal brain injuryNature, 2013
- Human Milk CompositionPediatric Clinics of North America, 2013
- Intranasal delivery of biologics to the central nervous systemAdvanced Drug Delivery Reviews, 2012
- High levels of growth factors in human breast milkEarly Human Development, 2008